Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder

Phase 4 Completed 395 enrolled Novartis Procter and Gamble · collab

RandomizedParallel-groupOpen-label

Summary

This study is designed to investigate the efficacy and safety of treatment of overactive bladder with darifenacin administered alone or in conjunction with behavioral modification therapies.

Timeline

Start: 2005-05
Primary completion: —
Completion: 2006-02

Publications

Funada S, Yoshioka T, Luo Y, Sato A, Akamatsu S, Watanabe N. Bladder training for treating overactive bladder in adults. Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD013571. doi: 10.1002/14651858.CD013571.pub2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Darifenacin	Small molecule	7.5 mg	—
Subject	Darifenacin	Small molecule	15 mg	—

Indications

No indication recorded.